A New Zealand company could potentially land a NZ $160 million contract, supplying Hemp as Medicine to a U.S. company.
The NZ company, Hikurangi Cannabis Company, would grow and produce 3000kg of pharmaceutical grade cannabis to Rhizo Sciences, in Seattle.
The deal is subject to a law change in New Zealand, that is expected to go through later this year.
This contract would confirm a very profitable future for the Ruatoria region, and for New Zealand in general. It would boost the economy and bring new employment opportunities.
Click here to read more.